NCT03363906View on ClinicalTrials.gov

A Study of Dulaglutide in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

June 6, 2018

Study Completion Date

June 6, 2018

Conditions
Healthy
Interventions
DRUG

Dulaglutide (Reference)

Administered SC

DRUG

Dulaglutide (Test)

Administered SC

Trial Locations (1)

75247

Covance Dallas, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03363906 - A Study of Dulaglutide in Healthy Participants | Biotech Hunter | Biotech Hunter